Dr. Vinod Thourani with Piedmont Heart gives the trial summary of the PARTNER 3 and Evolut trials at the 13th Annual Piedmont Heart Napa Cardiology Conference. He goes into the implications of 5-year PARTNER and 4-year Evolution LR trial data. This conference is a prestigious national conference dedicated to providing the latest updates and advancements in the field of heart disease and prevention.